INTEGRATED CORE STRATEGIES (US) LLC - 04 Feb 2026 SCHEDULE 13G Report for Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share
Symbol
KPTI
Shares outstanding
18,339,309 shares
Disclosed Ownership
1,008,662 shares
Ownership
5.5%
Form type
SCHEDULE 13G
Filing time
10 Feb 2026, 16:48:45 UTC
Date of event
04 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"INTEGRATED CORE STRATEGIES (US) LLC disclosed 5.5% ownership in Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI) on 04 Feb 2026."

Quick Takeaways

  • INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G for Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI).
  • Disclosed ownership: 5.5%.
  • Date of event: 04 Feb 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 10 Feb 2026, 16:48.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 5.4% 997,577 0 997,577 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 5.5% 1,008,662 0 1,008,662 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 5.5% 1,008,662 0 1,008,662 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 5.5% 1,008,662 0 1,008,662 /s/ Israel A. Englander Israel A. Englander

Sponsored